Related Experiment Video
Updated: May 26, 2026
Derivation of Enriched Oligodendrocyte Cultures and Oligodendrocyte/Neuron Myelinating Co-cultures from Post-natal Murine Tissues
Published on: August 21, 2011
Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells
Zoe Gale1, Paul R Cooper, Ben A Scheven
1School of Dentistry, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Abstract:
Little is known about the role of neurotrophic growth factors in bone metabolism. This study investigated the short-term effects of glial cell line-derived neurotrophic factor (GDNF) on calvarial-derived MC3T3-E1 osteoblasts. MC3T3-E1 expressed GDNF as well as its canonical receptors, GFRα1 and RET. Addition of recombinant GDNF to cultures in serum-containing medium modestly inhibited cell growth at high concentrations; however, under serum-free culture conditions GDNF dose-dependently increased cell proliferation. GDNF effects on cell growth were inversely correlated with its effect on alkaline phosphatase (AlP) activity showing a significant dose-dependent inhibition of relative AlP activity with increasing concentrations of GDNF in serum-free culture medium. Live/dead and lactate dehydrogenase assays demonstrated that GDNF did not significantly affect cell death or survival under serum-containing and serum-free conditions. The effect of GDNF on cell growth was abolished in the presence of inhibitors to GFRα1 and RET indicating that GDNF stimulated calvarial osteoblasts via its canonical receptors. Finally, this study found that GDNF synergistically increased tumor necrosis factor-α (TNF-α)-stimulated MC3T3-E1 cell growth suggesting that GDNF interacted with TNF-α-induced signaling in osteoblastic cells. In conclusion, this study provides evidence for a direct, receptor-mediated effect of GDNF on osteoblasts highlighting a novel role for GDNF in bone physiology.
Insights
Glial cell line-derived neurotrophic factor (GDNF) promotes osteoblast proliferation and inhibits alkaline phosphatase activity in a receptor-mediated manner, suggesting a novel role in bone metabolism.
Area of Science:
- Bone biology and osteoblast differentiation.
- Neurotrophic factors and their role in non-neuronal tissues.
Background:
- The function of neurotrophic factors in bone metabolism remains largely unexplored.
- Glial cell line-derived neurotrophic factor (GDNF) is a key neurotrophic factor with potential roles beyond the nervous system.
Purpose of the Study:
- To investigate the short-term effects of GDNF on MC3T3-E1 osteoblasts.
- To elucidate the mechanism of GDNF action and its interaction with other signaling pathways in osteoblasts.
Main Methods:
- Culturing MC3T3-E1 osteoblasts and treating them with recombinant GDNF.
- Assessing cell proliferation, alkaline phosphatase (ALP) activity, and cell viability.
- Utilizing receptor inhibitors (GFRα1 and RET) to confirm receptor-mediated effects.
- Investigating the interaction between GDNF and tumor necrosis factor-alpha (TNF-α) signaling.
Main Results:
- MC3T3-E1 cells express GDNF and its receptors GFRα1 and RET.
- GDNF dose-dependently increased cell proliferation under serum-free conditions.
- GDNF significantly inhibited ALP activity in a dose-dependent manner under serum-free conditions.
- GDNF did not affect cell viability but acted via its canonical receptors (GFRα1/RET).
- GDNF synergistically enhanced TNF-α-stimulated osteoblast growth.
Conclusions:
- GDNF exerts direct, receptor-mediated effects on osteoblasts.
- GDNF plays a novel role in modulating osteoblast proliferation and differentiation.
- GDNF signaling interacts with TNF-α pathways in osteoblastic cells, highlighting its broader physiological relevance.
